EUCTR2022-000642-16-GR进行中（未招募）1 期
Hydrogen sulfate guided therapy with STS for COVID-19 patients in need of critical care: The H4COVID open-label, randomized, triple-arm trial
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Age equal to or older than 18 years
- •-Both genders
- •-For women of childbearing potential, they must use or be willing to use a dual contraceptive method during the study.
- •-Written consent statement provided by the patient or his / her legal representative in case patients are unable to consent.
- •-Confirmed COVID-19 disease
- •-WHO-CPS 7 to 9
- •-Hospitalization in Intensive Care Unit
- •-Serum H2S levels less than 140 µM
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 15
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 15
排除标准
- •-Age less than 18 years
- •-Denial of written consent
- •-Decision not to resuscitate
研究者
相似试验
招募中
2 期
STS Administration on Coronavirus Disease (COVID-19) Patients in Critical CareCOVID-19Virus DiseasesCorona Virus InfectionNCT05277285Hellenic Institute for the Study of Sepsis30
已完成
不适用
Clinical implications of plasma hydrogen sulphide level in in Japanese people with type 2 diabetepatients with type 2 diabetes and patients without diabetesJPRN-UMIN000020549Department of Endocrinology and Metabolism, Dokkyo Medical University300
已完成
2 期
A phase ll study of TS-1+L-OHP(SOX) therapy for Her2-negative advanced/metastatic gastric cancer with measurable lesions (OGSG1405)Gastric carcinomaJPRN-UMIN000016972Osaka Gastrointestinal Cancer Chemotherapy Study Group55
已完成
不适用
Impact of high flow oxygen therapy on outcomes of COVID-19 patientsCTRI/2020/10/028634Rajendra Institute of Medical Sciences114
已完成
1 期
"Add-back" therapy with HSV-TK gene transduced donor lymphocytes after T-cell-depleted haplo-identical hematopoietic stem cell transplantatioHigh risk hematological malignancies, which require allogeneic stem cell transplantation therapy, without HLA- full match or 1 locus mismatch donorsJPRN-UMIN000002502ational Cancer Center Hospital10